Latest Breaking News On - Emergent biosolutions inc - Page 4 : comparemela.com

Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case of an.

United statesJoe papaRichards lindahlAssal hellmerEmergent biosolutions incUs department of educationKey survey findingsBryter incBryter globalNasal sprayOpioid crisis among americaUrgent needWhite house officeNational drug control policyRegan udallBuild awareness

Emergent BioSolutions Reports First Quarter 2024 Financial

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of.

United statesJoe papaAssal hellmerJosephc papaCompany cantonUs department of defenseCompany camdenDevelopment expensesExchange commissionEmergent biosolutions incFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed

Emergent BioSolutions Reports First Quarter 2024 Financial Results

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 millionUpdates FY 2024 guidance .

United statesJosephc papaJoe papaAssal hellmerEmergent biosolutions incExchange commissionDevelopment expensesCompany camdenUs department of defenseCompany cantonFirst quarterNet incomeDiluted shareSegment gross marginSegment adjusted gross marginAnthrax vaccine adsorbed

Emergent BioSolutions Announces Amendment to its Existing Credit Facility

Emergent BioSolutions Announces Amendment to its Existing Credit Facility
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Assal hellmerRichards lindahlJoe papaEmergent biosolutions incExchange commissionApple podcastsPrivate securities litigation reform actVice president

Emergent BioSolutions Announces Amendment to its Existing

GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and.

Richards lindahlJoe papaAssal hellmerExchange commissionEmergent biosolutions incApple podcastsPrivate securities litigation reform actVice presidentNyse ebsEmergent biosolutions